Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1273 |
|---|---|
| Identifier | NCT00502294 |
| Trial Title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Intravenous Steroid-Refractory Ulcerative Colitis |
| Interventions | DRUG: Visilizumab (HuM291; Nuvion) |
Participant Information
| Sponsor | Facet Biotech |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | - |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |